BioNews Texas | MD Anderson Researcher Reports Idelalisib and Rituximab Produce Responses ... BioNews Texas Idelalisib Dr. Susan M. O'Brien from the University of Texas MD Anderson Cancer Center in Houston reported that pairing rituximab with the experimental agent idelalisib can improve the management of small lymphocytic lymphoma or treatment- naive ... |
